Betaliq, Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Nebivolol 0.5, 1.0, or Timolol 0.5 Suspension Compared to Timolol 0.5 Solution to Treat Glaucoma/Ocular Hypertension (NCT04910100) | Betaliq, Inc. | 2021-04-15 |
Track Betaliq, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.